Business
Picard Medical, Inc. Announces Closing of $17 Million Initial Public Offering
TUCSON, Ariz., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Picard Medical, Inc. (NYSE American: PMI) (“Picard” or the “Company”), today announced that it closed its initial public offering of 4,250,000 shares of common stock, par value $0.0001 per share (the “Common Stock”) at $4.00 per share (the “Offering”). The Company has granted the underwriters an option, within 30 days from the closing date of the Offering, to purchase up to an additional 637,500 shares of Common Stock the public offering price, l
About this update from Picard Medical, Inc.
[{"type":"image","alt":"Picard Medical, Inc.","displaySize":"","headline":null,"caption":"Picard Medical, Inc.","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":266,"url":"https://media.zenfs.com/en/globenewswire.com/7aed5ca33d8d3f4fa4e291322577bb8f"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/GgCsyHKApDgH7PlfNRrYtw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTM3MjtjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/7aed5ca33d8d3f4fa4e291322577bb8f","width":300,"height":266}},"lazy":false},{"type":"text","content":"TUCSON, Ariz., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Picard Medical, Inc. (NYSE American: PMI) (“Picard” or the “Company”), today announced that it closed its initial public offering of 4,250,000 shares of common stock, par value $0.0001 per share (the “Common Stock”) at $4.00 per share (the “Offering”). The Company has granted the underwriters an option, within 30 days from the closing date of the Offering, to purchase up to an additional 637,500 shares of Common Stock the public offering price, less underwriting discounts, to cover over-allotment, if any. The gross proceeds from the offering were $17 million, before deducting underwriting discounts and estimated offering expenses. The shares began trading on the NYSE American, LLC (“NYSE American”) under the ticker symbol “PMI” on August 29, 2025.","length":807,"tagName":"p"},{"type":"text","content":"WestPark Capital, Inc. was Lead Manager and Sole Bookrunner for the Offering and representative of the underwriters for the Offering. Sentinel Brokers Co., Inc. was Co-Manager. E.F. Hutton & Co. and Uphorizon, LLC were financial advisors to the issuer.","length":256,"tagName":"p"},{"type":"text","content":"The offering was made only by means of a prospectus, copies of which may be obtained from WestPark Capital, Inc. by email at [email protected] or via standard mail to WestPark Capital, Inc., 1800 Century Park East, Suite 220, Los Angeles, CA 90067, or from the SEC website at www.sec.gov.","length":289,"tagName":"p"},{"type":"text","content":"A registration statement relating to these securities was declared effective by the Securities and Exchange Commission (“SEC”) on August 12, 2025.","length":146,"tagName":"p"},{"type":"text","content":"This press release shall not constitute an offer to sell or a solicitation of an offer to buy, nor shall there be an...